Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

European Medicines Agency validates submission of MAA for Nidlegy

Nidlegy is partnered with Sun Pharma for the treatment of Skin Cancers in Europe, New Zealand and Australia. Both companies jointly made the following announcements: - 23 October 2023 - Phase III PIVOTAL trial met the primary endpoint

By: business-standard.com

Jul 04 2024
53
7622 Views

European Medicines Agency validates submission of MAA for Nidlegy

European Medicines Agency validates submission of MAA for Nidlegy

Related

FPIs put Rs 7.9K cr in equities in July, investment over Rs 1 trn in 2024

Global trends, earnings from TCS, HCLTech to guide mkts this week: Analysts

Mcap of 8 most-valued firms jumps Rs 1.83 tn; TCS, Infosys biggest gainers

PEL board OKs ad hoc appointments post Rupen Patel's passing

Emcure Pharmaceuticals IPO ends with stellar subscription

Tricom Fruit Products reports standalone net loss of Rs 0.05 crore in the June 2024 quarter

Info Edge Q1 FY25 billings climb 11% YoY

Bansal Wire Industries IPO ends with strong subscription

IndusInd Bank advances climb 16% YoY in Q1 FY25

Adani Wilmar reports 13% volume growth in Q1 FY25

Share India Securities allots 16.92 lakh equity shares on conversion of warrants

Marico's domestic biz sees modest volume growth in Q1

FPIs put Rs 7.9K cr in equities in July, investment over Rs 1 trn in 2024